UNSPSC 85446202: The diagnosis of lipotropic drugs

In this classification, this covers the group of activities that yields a diagnosis of lipotropic drugs. Lipotropic drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y57.1.

UNSPSC 85446202 The diagnosis of lipotropic drugs, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally designates pharmaceutical diagnostic services, yet the three most recent opportunities tagged to it involve diagnostic imaging systems, special education contracted services, and clinical staffing — none of which concern lipotropic drug diagnosis or pharmaceutical testing. San Mateo Medical Center's October 2026 RFP for a Diagnostic Imaging PACS system addresses picture archiving and communication infrastructure for radiology, cardiology, and mammography, requiring EPIC EHR integration and 99.9% uptime; Birdville Independent School District's October 2026 RFQ seeks special education professionals including audiologists, speech therapists, and board certified behavior analysts; and Santa Clara Health System's October 2026 RFQ establishes a qualified vendor pool for temporary ancillary clinical staffing across 13 specialties including diagnostic imaging and respiratory care. None of these solicitations procure diagnostic laboratory services, pharmaceutical testing, or lipotropic-drug-related work.

The code exhibits sparse and misaligned activity. When the source does attach this code to state and local opportunities, the actual buying falls outside its stated scope — health system administrative infrastructure, school district support services, and temporary clinical staffing. Pursuing contracts under this code requires clarifying whether state and local procurement offices are tagging opportunities incorrectly or whether the code itself is in disuse for legitimate pharmaceutical diagnostics work. Recent issuing bodies (a county medical center, an independent school district, and a county health system) do not suggest active procurement of lipotropic drug diagnostic services under the code at this time.